Taejon, South Korea

Sun Kyung Hwang

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Dongbu Hannong Chemical Co., Ltd., Korea Research Institute of Chemical Technology, Schaeffler Technologies Ag & Co .Kg. Active years: 2001-2008.


% Patents Active = 40.0



Average Co-Inventor Count = 11.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Pusan-si, KR (2001)
  • Taejon-si, KR (2007 - 2008)
  • Taejeon-si, KR (2007 - 2008)

Company Filing History:


Years Active: 2001-2008

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Sun Kyung Hwang

Introduction

Sun Kyung Hwang is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that protect the heart from ischemia-reperfusion injury. With a total of 5 patents to his name, Hwang's work is recognized for its potential impact on medical treatments.

Latest Patents

Hwang's latest patents include innovative compounds such as benzopyran derivatives substituted with a thioxobenzoxazole derivative. These compounds, along with their pharmaceutically acceptable salts, are designed to protect the heart from ischemia-reperfusion both in vivo and in vitro. The pharmaceutical compositions containing these derivatives can be effectively used for the protection of various tissues influenced by ischemia-reperfusion, including the heart, nervous cells, and brain. Another significant patent involves furancarbonylguanidine derivatives, which inhibit NHE-1 (sodium-hydrogen exchanger isoform 1). This inhibition aids in the recovery of heart function damaged from ischemia/reperfusion and decreases the myocardial infarction rate, making these derivatives promising candidates for treating ischemic heart diseases.

Career Highlights

Throughout his career, Sun Kyung Hwang has worked with esteemed organizations such as the Korea Research Institute of Chemical Technology and Dongbu Hannong Chemical Co., Ltd. His research has focused on developing pharmaceutical compositions that can significantly improve heart health and recovery.

Collaborations

Hwang has collaborated with notable colleagues, including Kyu Yang Yi and Sun Kyung Lee, who have contributed to his research endeavors. Their combined expertise has furthered the development of innovative solutions in the pharmaceutical field.

Conclusion

Sun Kyung Hwang's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving heart health and treatment options. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…